Skip to main content

Table 1 Demographic characteristics and comorbidities for the osteoporosis and comparison cohorts from 2003 to 2005 ( N =8190)

From: Osteoporosis increases subsequent risk of gallstone: a nationwide population-based cohort study in Taiwan

 

Patients with osteoporosis ( n =1638)

Patients without osteoporosis ( n =6552)

P value

 

n

%

n

%

 

Sex

    

1

 Male

242

14.8

968

14.8

 

 Female

1396

85.2

5584

85.2

 

Age (y)

    

1

 50–64

648

39.6

2592

39.6

 

 65–79

808

49.3

3232

49.3

 

 ≥ 80

182

11.1

728

11.1

 

Mean ± SD of follow-up (y)

    

< .001

 

4.76

0.97

4.88

0.66

 

Urbanization level

    

0.037

 1 (most urbanized)

443

27.0

2010

30.7

 

 2

452

27.6

1688

25.8

 

 3

229

14.0

929

14.2

 

 4

264

16.1

1035

15.8

 

 5 (least urbanized)

250

15.3

890

13.6

 

Monthly income

    

0.006

 0

567

34.6

2520

38.5

 

 NT$ 1–15,840

245

15.0

809

12.3

 

 NT$ 15,841–25,000

695

42.4

2724

41.6

 

 NT$ –25,001

131

8.0

499

7.6

 

Geographic region

    

< .001

 Northern

687

41.9

2953

45.1

 

 Central

467

28.5

1630

24.9

 

 Southern

355

21.7

1566

23.9

 

 Eastern

129

7.9

403

6.2

 

Hypertension

    

< .001

 Yes

1212

74.0

4548

69.4

 

 No

426

26.0

2004

30.6

 

Hyperlipidemia

    

< .001

 Yes

895

54.6

2914

44.5

 

 No

743

45.4

3638

55.5

 

Diabetes

    

0.008

 Yes

658

40.2

2399

36.6

 

 No

980

59.8

4153

63.4

 

Liver cirrhosis

    

< .001

 Yes

368

22.5

900

13.7

 

 No

1270

77.5

5652

86.3

 

Hemolytic anemia

    

0.773

 Yes

2

0.1

10

0.2

 

 No

1636

99.9

6542

99.8

 

Spinal cord injury

    

<.001

 Yes

99

6.0

17

0.3

 

 No

1539

94.0

6535

99.7

 

Obesity

    

0.826

 Yes

10

0.6

37

0.6

 

 No

1628

99.4

6515

99.4

 

Hormone replacement

    

<.001

 Yes

231

14.1

298

4.5

 

 No

1407

85.9

6254

95.5

 

Ceftriaxone

    

0.813

 Yes

4

0.2

14

0.2

 

 No

1634

99.8

6538

99.8

 

Clofibrate

    

0.045

 Yes

1

0.1

Na

Na

 

 No

1637

99.9

6552

100.0

 

Octreotide

    

0.724

 Yes

2

0.1

6

0.1

 

 No

1636

99.9

6546

99.9

 

Total parenteral nutrition

    

0.070

 Yes

1

0.1

21

0.3

 

 No

1637

99.9

6531

99.7

Â